Pattern of recurrence during follow-up in the 549 patients included in the study
| Pattern of recurrence | Overall n=549 | PDS n=175 | Early IDS n=224 | DDS n=150 |
| Lymph node, n (%) | 181 (33.0) | 58 (33.1) | 73 (32.6) | 50 (33.3) |
| Peritoneal, n (%) | 313 (57.0) | 88 (50.3) | 135 (60.3) | 90 (60.0) |
| Pleural or pulmonary, n (%) | 71 (12.9) | 24 (13.7) | 38 (17.0) | 9 (6.0) |
| Other*, n (%) | 80 (14.6) | 22 (12.6) | 36 (16.1) | 22 (14.7) |
| Unique recurrence, n (%) | 270 (49.2) | 80 (45.7) | 110 (49.1) | 80 (53.3) |
| Multiple recurrence, n (%) | 168 (30.6) | 48 (27.4) | 78 (34.8) | 42 (28.0) |
*Other included metastatic localizations such as intra-parenchymatous hepatic (n=53), cerebral (n=8), intra-parenchymatous splenic (n=4), adrenal gland (n=3), bone (n=3), mammary gland (n=3), renal (n=1), and multiple metastatic localization (n=5).
DDS, delayed debulking surgery; IDS, early interval debulking surgery; PDS, primary debulking surgery.